Abstract:Highlights • We report for the first time the synthesis and validation of ultra-small Fe-DMY NCPs particles formed by coupling DMY with low-toxicity iron ions. • In vitro and in vivo experiments confirmed its ability of alleviating oxidative stress damage to vascular endothelial cells by high glucose, scavenging overproduced ROS and ameliorating pathological features of DR such as retinal vascular leakage and neovascularization. • Mechanistic validation suggested that Fe-DMY NCPs could inhibit the activation of Poldip2-Nox4-H2O2 signaling pathway and down-regulate important vascular function indicators such as VCAM-1, HIF-1α and VEGF. • We proved that Fe-DMY NCPs may be a novel polymeric drug with therapeutic potential for DR as a safe and efficient antioxidant and microangio-protective agent. Diabetic retinopathy (DR) is a prevalent microvascular complication of diabetes and the leading cause of blindness and severe visual impairment in adults. The high levels of glucose trigger multiple intracellular oxidative stress pathways, such as POLDIP2, resulting in excessive reactive oxygen species (ROS) production and increased expression of VCAM-1, HIF-1α, and VEGF, causing microvascular dysfunction. Dihydromyricetin (DMY) is a natural flavonoid small molecule antioxidant. However, it exhibits poor solubility in physiological environments, has a short half-life in vivo, and has low oral bioavailability. In this study, we present, for the first time, the synthesis of ultra-small Fe-DMY nano-coordinated polymer particles (Fe-DMY NCPs), formed by combining DMY with low-toxicity iron ions. In vitro and in vivo experiments confirm that Fe-DMY NCPs alleviate oxidative stress-induced damage to vascular endothelial cells by high glucose, scavenge excess ROS, and improve pathological features of DR, such as retinal vascular leakage and neovascularization. Mechanistic validation indicates that Fe-DMY NCPs can inhibit the activation of the Poldip2-Nox4-H 2 O 2 signaling pathway and downregulate vital vascular function indicators such as VCAM-1, HIF-1α, and VEGF. These findings suggest that Fe-DMY NCPs could serve as a safe and effective antioxidant and microangio-protective agent, with the potential as a novel multimeric drug for DR therapy. Graphical abstract Schematic diagram of preparation process and DR protection of Fe-DMY NCPs. Ultrasmall Fe-DMY coordination polymer nanoparticles (Fe-DMY NCPs) are formed by coupling DMY with low toxic iron ions. Fe-DMY NCPs can reduce the oxidative stress damage of high glucose on vascular endothelial cells, eliminate excess ROS and improve the pathological characteristics of DR (such as retinal vascular leakage and neovascularization), inhibit the activation of Poldip2-Nox4-H 2 O 2 signal pathway, and down regulate important vascular function indicators, such as VCAM-1, HIF-1 α and VEGF. Fe-DMY NCPs may be a safe and effective antioxidant and microvascular protector, which has the potential to treat DR and is a new type of polymer drug. Download : Download high-res image (295KB) Download : Download full-size image

Drag-Reducing Polymers Improve Vascular Hemodynamics and Tissue Oxygen Supply in Mouse Model of Diabetes Mellitus

A Rat Model of Studying Tissue-Type Plasminogen Activator Thrombolysis in Ischemic Stroke with Diabetes

Sustained Release of Stromal Cell-Derived Factor-1α from Injectable Hydrogels in Combination with Endothelial Progenitor Cells Effectively Promotes Neovascularization in Ischemic Diabetic Rats

Diabetic microangiopathy: impact of impaired cerebral vasoreactivity and delayed angiogenesis after permanent middle cerebral artery occlusion on stroke damage and cerebral repair in mice

Vessel Dilation Attenuates Endothelial Dysfunction Following Middle Cerebral Artery Occlusion in Hyperglycemic Rats

Abstract WP297: Time-Dependent Effects of Drag-Reducing Polymers Administration on Permanent Middle Cerebral Artery Occlusion Injury in Rats

Characterization of Retinal Microvascular Complications and the Effects of Endoplasmic Reticulum Stress in Mouse Models of Diabetic Atherosclerosis

Synchronized Research on Endothelial Dysfunction and Microcirculation Structure in Dorsal Skin of Rats with Type 2 Diabetes Mellitus

Microvascular Shunts, Intracranial Pressure, and the Impact of Drag-Reducing Polymers

Comparison of Cerebral Microcirculation of Alloxan Diabetes and Healthy Mice Using Laser Speckle Contrast Imaging

Abstract 606: Pharmacological Inhibition of PAI-1 Rescues Blood Flow Perfusion Through Promoting Capillary Arterialization in Diabetic Microangiopathy in Ischemic Limb

Synergistic Effects of Transplanted Endothelial Progenitor Cells and RWJ 67657 in Diabetic Ischemic Stroke Models

Impact of the acute local inhibition of soluble epoxide hydrolase on diabetic skin microcirculatory dysfunction

Reconstituted high-density lipoproteins rescue diabetes-impaired endothelial cell metabolic reprograming and angiogenic responses to hypoxia

Resolvin D1 Inhibits Endothelial Permeability and Mitochondrial Damage Following Cardiac Ischemia Reperfusion in Diabetic Mice

Abstract WP296: Human Vascular Smooth Muscle Cells Derived Small Extracellular Vesicles Reduce the Neurovascular Damage After Stroke in Diabetic Mice

Curcumin Induces Therapeutic Angiogenesis in a Diabetic Mouse Hindlimb Ischemia Model Via Modulating the Function of Endothelial Progenitor Cells

Endothelial Deletion of Mtorc1 Protects Against Hindlimb Ischemia in Diabetic Mice Via Activation of Autophagy, Attenuation of Oxidative Stress and Alleviation of Inflammation.

PPARδ activation protects endothelial function in diabetic mice

Decreased Mobilization of Endothelial Progenitor Cells Contributes to Impaired Neovascularization in Diabetes

Nanoscale Coordination Polymer Fe-DMY Downregulating Poldip2-Nox4-H 2 O 2 Pathway and Alleviates Diabetic Retinopathy